DPP9

{{Short description|Protein-coding gene in humans}}

{{cs1 config|name-list-style=vanc|display-authors=6}}

{{Infobox_gene}}

Dipeptidyl peptidase 9 is an enzyme that in humans is encoded by the DPP9 gene.{{cite web | title = Entrez Gene: DPP9 dipeptidyl-peptidase 9| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=91039}}

Function

This gene encodes a protein that is a member of the S9B family in clan SC of the serine proteases. The protein has been shown to have post-proline dipeptidyl aminopeptidase activity, cleaving Xaa-Pro dipeptides from the N-termini of proteins. Although the activity of this protein is similar to that of dipeptidyl peptidase 4 (DPP4), it does not appear to be membrane bound.

In general, dipeptidyl peptidases appear to be involved in the regulation of the activity of their substrates and have been linked to a variety of diseases including type 2 diabetes, obesity and cancer. Several transcript variants of this gene have been described but not fully characterized. More specifically, DPP9 interacts with the NLRP1 protein and affects the level of activation of the NLRP1 inflammasome. This function involves binding to a complex of full-length NLRP1 and a proinflammatory fragment of NLRP1 after activation by autocleavage.{{cite journal | vauthors = Hollingsworth LR, Sharif H, Griswold AR, Fontana P, Mintseris J, Dagbay KB, Paulo JA, Gygi SP, Bachovchin DA, Wu H | title = DPP9 sequesters the C terminus of NLRP1 to repress inflammasome activation | journal = Nature | volume = 592 | issue = 7856 | pages = 778–783 | date = April 2021 | pmid = 33731932 | pmc = 8299537 | doi = 10.1038/s41586-021-03350-4 | bibcode = 2021Natur.592..778H }}{{cite journal | vauthors = Huang M, Zhang X, Toh GA, Gong Q, Wang J, Han Z, Wu B, Zhong F, Chai J | title = Structural and biochemical mechanisms of NLRP1 inhibition by DPP9 | journal = Nature | volume = 592 | issue = 7856 | pages = 773–777 | date = April 2021 | pmid = 33731929 | pmc = 8081665 | doi = 10.1038/s41586-021-03320-w | bibcode = 2021Natur.592..773H }} A similar mechanism allows DPP9 to regulate the CARD8 inflammasome.{{cite journal | vauthors = Sharif H, Hollingsworth LR, Griswold AR, Hsiao JC, Wang Q, Bachovchin DA, Wu H | title = Dipeptidyl peptidase 9 sets a threshold for CARD8 inflammasome formation by sequestering its active C-terminal fragment | journal = Immunity | volume = 54 | issue = 7 | pages = 1392–1404.e10 | date = July 2021 | pmid = 34019797 | pmc = 8423358 | doi = 10.1016/j.immuni.2021.04.024 }}

Animal studies

Genetic analysis of knockout alleles of DPP9 in mice and zebrafish showed a severe phenotype that could be rescued by mutation of NLPR1.

Clinical significance

Mutations in NLRP1 that block DPP9 interaction lead to a rare Mendelian condition called Autoinflammation with Arthritis and Dyskeratosis{{cite web | title = Autoinflammation With Arthritis and Dyskeratosis; AIADK | id = 617388 | url = https://www.omim.org/entry/617388 | website = Online Mendelian Inheritance in Man | date = }}{{cite journal | vauthors = Zhong FL, Robinson K, Teo DE, Tan KY, Lim C, Harapas CR, Yu CH, Xie WH, Sobota RM, Au VB, Hopkins R, D'Osualdo A, Reed JC, Connolly JE, Masters SL, Reversade B | title = Human DPP9 represses NLRP1 inflammasome and protects against autoinflammatory diseases via both peptidase activity and FIIND domain binding | journal = The Journal of Biological Chemistry | volume = 293 | issue = 49 | pages = 18864–18878 | date = December 2018 | pmid = 30291141 | pmc = 6295727 | doi = 10.1074/jbc.RA118.004350 | doi-access = free }} A homozygous recessive syndrome dubbed Hatipoğlu syndrome is attributed to mutations in DPP9 with a phenotype of failure to thrive, skin manifestations, pancytopenia, and susceptibility to infections.{{cite journal | vauthors = Harapas CR, Robinson KS, Lay K, Wong J, Moreno Traspas R, Nabavizadeh N, Rass-Rothschild A, Boisson B, Drutman SB, Laohamonthonkul P, Bonner D, Xiong JR, Gorrell MD, Davidson S, Yu CH, Fleming MD, Gudera J, Stein J, Ben-Harosh M, Groopman E, Shimamura A, Tamary H, Kayserili H, Hatipoğlu N, Casanova JL, Bernstein JA, Zhong FL, Masters SL, Reversade B | title = DPP9 deficiency: An inflammasomopathy that can be rescued by lowering NLRP1/IL-1 signaling | journal = Science Immunology | volume = 7 | issue = 75 | pages = eabi4611 | date = September 2022 | pmid = 36112693 | pmc = 9844213 | doi = 10.1126/sciimmunol.abi4611 | hdl-access = free | hdl = 10754/681562 }}{{Clear}}

This gene has also been linked to severe COVID-19.{{cite journal | vauthors = Ferreira LC, Gomes CE, Rodrigues-Neto JF, Jeronimo SM | title = Genome-wide association studies of COVID-19: Connecting the dots | journal = Infection, Genetics and Evolution | volume = 106 | issue = | pages = 105379 | date = December 2022 | pmid = 36280088 | pmc = 9584840 | doi = 10.1016/j.meegid.2022.105379 | bibcode = 2022InfGE.10605379F }}

References

{{reflist}}

Further reading

{{refbegin | 2}}

  • {{cite journal | vauthors = Olsen C, Wagtmann N | title = Identification and characterization of human DPP9, a novel homologue of dipeptidyl peptidase IV | journal = Gene | volume = 299 | issue = 1–2 | pages = 185–193 | date = October 2002 | pmid = 12459266 | doi = 10.1016/S0378-1119(02)01059-4 }}
  • {{cite journal | vauthors = Ajami K, Abbott CA, Obradovic M, Gysbers V, Kähne T, McCaughan GW, Gorrell MD | title = Structural requirements for catalysis, expression, and dimerization in the CD26/DPIV gene family | journal = Biochemistry | volume = 42 | issue = 3 | pages = 694–701 | date = January 2003 | pmid = 12534281 | doi = 10.1021/bi026846s }}
  • {{cite journal | vauthors = Qi SY, Riviere PJ, Trojnar J, Junien JL, Akinsanya KO | title = Cloning and characterization of dipeptidyl peptidase 10, a new member of an emerging subgroup of serine proteases | journal = The Biochemical Journal | volume = 373 | issue = Pt 1 | pages = 179–189 | date = July 2003 | pmid = 12662155 | pmc = 1223468 | doi = 10.1042/BJ20021914 }}
  • {{cite journal | vauthors = Ajami K, Abbott CA, McCaughan GW, Gorrell MD | title = Dipeptidyl peptidase 9 has two forms, a broad tissue distribution, cytoplasmic localization and DPIV-like peptidase activity | journal = Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression | volume = 1679 | issue = 1 | pages = 18–28 | date = July 2004 | pmid = 15245913 | doi = 10.1016/j.bbaexp.2004.03.010 }}
  • {{cite journal | vauthors = Ogasawara W, Tanaka C, Suzuki M, Kobayashi G, Ogawa Y, Okada H, Morikawa Y | title = Isoforms of dipeptidyl aminopeptidase IV from Pseudomonas sp. WO24: role of the signal sequence and overexpression in Escherichia coli | journal = Protein Expression and Purification | volume = 41 | issue = 2 | pages = 241–251 | date = June 2005 | pmid = 15866709 | doi = 10.1016/j.pep.2004.10.027 }}
  • {{cite journal | vauthors = Bjelke JR, Christensen J, Nielsen PF, Branner S, Kanstrup AB, Wagtmann N, Rasmussen HB | title = Dipeptidyl peptidases 8 and 9: specificity and molecular characterization compared with dipeptidyl peptidase IV | journal = The Biochemical Journal | volume = 396 | issue = 2 | pages = 391–399 | date = June 2006 | pmid = 16475979 | pmc = 1462722 | doi = 10.1042/BJ20060079 }}
  • {{cite book | vauthors = Yu DM, Wang XM, Ajami K, McCaughan GW, Gorrell MD | title = Dipeptidyl Aminopeptidases | chapter = DP8 and DP9 have extra-enzymatic roles in cell adhesion, migration and apoptosis | volume = 575 | pages = 63–72 | year = 2006 | pmid = 16700509 | doi = 10.1007/0-387-32824-6_7 | isbn = 978-0-387-29058-4 | series = Advances in Experimental Medicine and Biology }}
  • {{cite journal | vauthors = Yu DM, Wang XM, McCaughan GW, Gorrell MD | title = Extraenzymatic functions of the dipeptidyl peptidase IV-related proteins DP8 and DP9 in cell adhesion, migration and apoptosis | journal = The FEBS Journal | volume = 273 | issue = 11 | pages = 2447–2460 | date = June 2006 | pmid = 16704418 | doi = 10.1111/j.1742-4658.2006.05253.x | s2cid = 19075840 | doi-access = free }}

{{refend}}

{{gene-19-stub}}